Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-22.84	84.48	109.49
Graham Fair Price	8.14	18.03	16.67
PEG	-42.57	2.12	-3.69
Price/Book	-16.99	14.99	18.05
Price/Cash Flow	29.09	166.59	129.06
Prices/Earnings	-26.35	31.64	42.96
Price/Sales	-15.09	34.61	40.76
Price/FCF	29.09	166.59	129.06
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	5.27	0.71	0.67
Operating Margin	9.23	0.37	0.33
ROA	13.60	0.04	0.04
ROE	0.11	0.12	12.72
ROIC	0.05	0.05	7.04
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	49.78
Dividends QOQ	< 0.005	0.16	2154.02
EBIT QOQ	-0.06	0.08	25.74
EPS QOQ	-0.12	0.15	28.25
FCF QOQ	0.21	-0.35	68.43
Revenue QOQ	0.03	-0.01	-63.94
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	316.98	371.06	17.06
Days Sales Outstanding (DSO)	53.03	53.14	0.20
Inventory Turnover	0.28	0.24	-14.57
Debt/Capitalization	0.57	0.57	-0.42
Quick Ratio	1.77	3.85	117.50
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	10.84	11.04	1.86
Cash	4.42	13.22	198.83
Capex	-0.43	-0.31	28.85
Free Cash Flow	1.52	0.99	-34.50
Revenue	4.80	4.78	-0.42
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.36	3.33	-0.80
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	5.44	5.03	-7.56
Naive Interpretation	Member

06 - Financial Health · Bad

Rating